D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes
about
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidityA meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?Dopamine and glucose, obesity, and reward deficiency syndromeThe TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese womenSystematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programsReward mechanisms in obesity: new insights and future directions.Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sampleThe role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factorsLow Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.Ventromedial prefrontal cortex response to concentrated sucrose reflects liking rather than sweet quality codingNutrigenomic targeting of carbohydrate craving behavior: can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map?Dopamine D2 receptors and striatopallidal transmission in addiction and obesity.Food cravings, food addiction, and a dopamine-resistant (DRD2 A1) receptor polymorphism in Asian American college students.Alcoholism and liver disease in Mexico: genetic and environmental factors.Dietary triglycerides as signaling molecules that influence reward and motivation.Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus.Predictors for Reporting of Dietary Assessment Methods in Food-based Randomized Controlled Trials over a Ten-year Period.The role of prolactin in andrology: what is new?Associations between dopamine D2 receptor availability and BMI depend on age.Association of the gene expression variation of tumor necrosis factor-α and expressions changes of dopamine receptor genes in progression of diabetic severe foot ulcers.The neurobiology of appetite: hunger as addiction.Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project
P2860
Q26752342-9F10DD02-4732-49A5-A03B-E52BDAABD9CAQ26752845-DDDFA968-1464-4D25-AC47-8D329EF97156Q27003334-2D1F25AB-E44B-4F5E-B41C-CC35F3ED4AC8Q28396618-91399233-4B33-41BB-8AA2-040D7C724087Q33660225-5C426D69-6197-408A-BE54-37D61055072BQ34243903-6EE71DCF-1855-4139-ACD8-988FEF2F6004Q34626703-EEA7DDD1-5AF2-4061-8C18-352E1453C623Q34674976-4055BD5D-FF31-4E5A-8D06-74974B4E7CA0Q35165378-677A268F-A3CA-4735-AC8F-D69451549550Q35864617-49A781F4-B560-41C6-87B0-3228ED3455A8Q36505783-CFA186F5-07CA-48AF-B4E4-CA7867B334FFQ36670718-EC06C1CD-6646-4331-BE65-CB6B302F9C91Q37106084-09E74861-A0DD-4C76-96BE-FAB7E32EDC32Q37136652-0E35A588-EBB7-488E-9689-F5591F77CB50Q37237574-3E5E0D4C-92FF-4366-98DA-CFB3E1AC4508Q37255249-31D252D9-C1A5-49FB-85C4-842840EEEE47Q37358627-678159F4-DAC9-40FF-B220-EC78E68FB90DQ37629140-92EC2779-9C1A-4DE8-9F76-381E1A72CEE9Q37803304-B4EAE2E7-BFA6-475E-949F-3B3055EFD536Q38554771-0521163B-035A-4BE0-B919-D8652A3C4D90Q38626657-2868D2BA-B67B-46BF-987E-D5472D4A3918Q42496839-A3C738E0-F90F-4E1C-92E3-466FECD3017AQ47155984-CDE0A1A5-31DA-430B-B9FF-EF32957F279BQ52294801-5A44E49D-7AA5-4D1B-803B-2E5A4C40A8B2Q54360692-AFD7D3F3-4522-421A-8774-1C0AE4CA8448Q58418668-3A0D54BE-086A-4F76-A9DC-E3C48406219E
P2860
D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
D2 dopamine receptor Taq1A pol ...... tary intake in type 2 diabetes
@en
D2 dopamine receptor Taq1A pol ...... ary intake in type 2 diabetes.
@nl
type
label
D2 dopamine receptor Taq1A pol ...... tary intake in type 2 diabetes
@en
D2 dopamine receptor Taq1A pol ...... ary intake in type 2 diabetes.
@nl
prefLabel
D2 dopamine receptor Taq1A pol ...... tary intake in type 2 diabetes
@en
D2 dopamine receptor Taq1A pol ...... ary intake in type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
D2 dopamine receptor Taq1A pol ...... tary intake in type 2 diabetes
@en
P2093
Amber A Green
David J A Jenkins
Ernest P Noble
Hope Ferdowsian
Joshua Cohen
Lise Gloede
Neal D Barnard
Terry Ritchie
P2860
P356
10.1016/J.NUT.2008.07.012
P577
2008-10-02T00:00:00Z